AstraZeneca and MedImmune are committed to supporting quality independent education that:

  • Meet an educational need by providing information designed to assist health care professionals in their efforts to enhance patient care
  • Further the understanding of emerging therapies based on a documented unmet need
  • Incorporate evidence-based medicine in the program objectives and methodology
  • Assist health care professionals in carrying out diagnosis and treatment strategies more effectively and efficiently
  • Support the efforts of health care professionals to broaden patient knowledge and awareness of disease states and treatment options
  • Address performance and quality improvement

We focus our support where there is the greatest need in areas that overlap with our areas of interest.

We have incorporated Call for Grant Applications into our process. Please check available Call for Grants below.

Available funding for areas of educational interest

No funding available - check back periodically

Areas of Educational Interest Available Funding Call for Grants
CARDIOVASCULAR
Acute Coronary Syndrome
Heart Failure (HF)
Hypertriglyceridemia
ENDOCRINOLOGY
Type 2 Diabetes
MEDIMMUNE - Research & Development Support
Antibody Discovery & Protein Engineering
Biopharmaceutical Development
Cardio & Vascular Metabolic Disease
Clinical Operations
Infectious Diseases & Vaccines
Medimmune Biotech Operations
Oncology
Partnering & Strategy
Respiratory, Inflammation & Autoimmunity
Translational Science
United Kingdom Research
NEPHROLOGY
Chronic Kidney Disease (CKD)
Hyperkalemia
NEUROLOGY / PAIN
Opioid-Induced Constipation
ONCOLOGY
Advanced Breast Cancer
  • BRCA
  • Non-BRCA
  • DNA Damage Response
  • PARP inhibition
BRCAm+ Ovarian Cancer
  • PARP inhibition
  • DNA Damage Response
Hematology
  • CLL (Chronic Lymphocytic Leukemia)
  • MCL (Mantle Cell Lymphoma)
  • HCL (Hairy Cell Leukemia)
Immuno-Oncology
  • imAE Management
  • Non-Metastatic NSCLC
Metastatic Breast Cancer
  • HR+
Non Small Cell Lung Cancer
  • EGFRm+ NSCLC
  • EGFR T790m+ NSCLC
Prostate Cancer (mCRPC)
  • PARP inhibition
  • DNA Damage Response
RESPIRATORY
COPD (Accepting submissions ≤ $50,000)
Asthma
Severe Asthma
RHEUMATOLOGY/IMMUNOLOGY/AUTOIMMUNE
Systemic Lupus Erythematosus
RESEARCH & DEVELOPMENT
Scientific or educational activities designed to educate research scientists, principal researchers, drug development professionals, academics, pre-doctoral students, doctoral students and fellows. These programs must be educational and non-promotional in nature and planned, designed and implemented in accordance with the U.S. Food and Drug Administration's Guidance on Industry-Supported Scientific and Educational Activities